Search

everythinglearnresearchcommunity

for

Search:↓

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Skin rashes can help diagnose COVID-19 early.

People in high-income countries are more likely to accept COVID-19 booster doses than those in middle or low-income countries.

During the COVID-19 pandemic, a clinic in Turkey saw fewer patients but more cases of certain skin conditions, possibly linked to the virus and stress.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Many COVID-19 survivors experience long-lasting symptoms, including hair loss and psychological issues.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Many recovered COVID-19 patients in Saudi Arabia still experience symptoms like fatigue and anxiety, especially older adults and those with other health issues.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

Long COVID causes lasting symptoms and needs vaccines for prevention and a team approach for treatment.

Hospitalized COVID-19 survivors have a higher risk of long-term symptoms and need special care.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Finasteride improves surrounding scalp hair and increases hair density after hair transplant.

The Pfizer COVID-19 vaccine may rarely trigger nail psoriasis.

Certain skin rashes can indicate COVID-19 severity, with chilblains-like rashes linked to milder cases and livedoid patterns to more severe cases.

Patients reduced searches for dermatology issues during COVID-19, indicating a need for better telehealth services.

Testosterone's effects on COVID-19 are unclear and need more research.

People with myotonic dystrophy type 1 have a higher chance of getting skin tumors, including melanoma.

Finasteride improves surrounding scalp hair and increases hair density after hair transplant.

Rice bran extract might help prevent hair loss.

The French COVID-19 lockdown caused delays in diagnosing new melanoma cases, making them more severe.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

A skin rash after the AstraZeneca COVID-19 vaccine was treated successfully with medication.

Two existing drugs may help treat COVID-19 by inhibiting a key viral protein.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.